CCRN Flashcards [with CCRN Practice Questions]
Pharmacy Clarification of Prescriptions Ordered in Primary Care: A Report from the Applied Strategies for Improving Patient...
Specifically, prescriptions for gastrointestinal, cardiovascular and analgesic/anesthetic agents should be carefully evaluated ... cardiovascular (n = 278; 13.9%), and analgesic/anesthetic (n = 74; 13.2%) agents. Issues were resolved on the same day 62% of ... cardiovascular agents (n = 79; 13.9%), and analgesics and anesthetics (n = 74; 13.1%). The most frequent medications recorded ... It was not surprising that the most common reasons for callbacks of antiulcer/dyspepsia agents were regarding prior ...
Oral microbiome: a doubtful predictor but potential target of cardiovascular diseases
... posing potential threats to host cardiovascular health. Importantly, oral dysbiosis promotes cardiovascular pathophysiology ... Further extensive efforts are needed to deepen our understanding on oral-cardiovascular connection in the context of diagnostic ... However, targeting oral microbiome might still provide preventive and therapeutic insights on cardiovascular diseases. ... Antimicrobial agents can counteract oral dysbiosis through numerous antimicrobial activities, including the disruption on ...
These Adverse Events Linked to Improved Cancer Prognosis
Publications from Bentham Science Publishers - Sherpa Services
Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study...
Treated hypertension (diagnosis of hypertension and at least one current prescription of at least one antihypertensive agent) ... The age at which the cardiovascular disease risk reaches 50% is the expected age for a cardiovascular event to occur. In this ... We developed the model to estimate the lifetime risk of cardiovascular disease, with death (non-cardiovascular) accounted for ... We identified incident cases of cardiovascular disease based on the first recorded diagnosis of cardiovascular disease recorded ...
Thrombin@Fe3O4 nanoparticles for use as a hemostatic agent in internal bleeding | Scientific Reports
Mariinsky Hospital, Regional Cardiovascular Center, Liteyny Ave. 56, 191054, St. Petersburg, Russian Federation ... In order to perform targeted delivery of hemostatic agents further modification of their surface by targeting agents, such as ... Shabanova, E.M., Drozdov, A.S., Fakhardo, A.F. et al. Thrombin@Fe3O4 nanoparticles for use as a hemostatic agent in internal ... Development and assessment of kerateine nanoparticles for use as a hemostatic agent. Materials Science and Engineering: C 63, ...
Jana Zúrová-Nedelcevová - NeL.edu
Cardiovascular toxicity of the first line cancer chemotherapeutic agents: doxorubicin, cyclophosphamide, streptozotocin and ... Cardiovascular toxicity of the first line cancer chemotherapeutic agents: doxorubicin, cyclophosphamide, streptozotocin and ... Antineoplastic Agents:adverse effects, Bevacizumab, Cardiomyopathies:chemically induced, Chemokine CCL2:metabolism, ...
Teva to Present First Data Set from the CONNECT1 Clinical Trial on ProAir® Digihaler® (albuterol sulfate) Inhalation Powder at...
... or within 2 weeks of discontinuation of these agents, because the action of albuterol on the cardiovascular system may be ... Use of Anti-Inflammatory Agents: ProAir Digihaler alone may not be adequate to control asthma in many patients. Early ... Beta-Blockers: Beta-adrenergic-receptor blocking agents not only block the pulmonary effect of beta-agonists, such as ProAir ... Cardiovascular Effects: ProAir Digihaler, like other beta-adrenergic agonists, can produce clinically significant ...
Cellular stress response mechanisms of Rhizoma coptidis: a systematic review | Chinese Medicine
Then we summarized the mechanisms of these alkaloid components of Rhizoma coptidis on cardiovascular and cerebrovascular ... Rhizoma coptidis: a potential cardiovascular protective agent. Front Pharmacol. 2016;7:362. ... It can be employed in infectious diseases, cardiovascular diseases, diabetes and so on. Its new efficacy is also constantly ... Then we summarized the mechanisms of these alkaloid components of Rhizoma coptidis on cardiovascular and cerebrovascular ...
Pharmaceuticals | March 2021 - Browse Articles
Tilorone, an antiviral agent, can prevent fibrosis in a mouse model of lung disease. We investigated the anti-fibrotic effects ... Cardiac fibrosis is associated with most forms of cardiovascular disease. No reliable therapies targeting cardiac fibrosis are ... Both the agents were able to significantly improve the drying process, without altering the physico-chemical properties of the ... Tilorone, an antiviral agent, can prevent fibrosis in a mouse model of lung [...] Read more. ...
Ibuprofen - Rat Guide
Teva Generics Products Catalog
Cardiovascular Drugs / Antilipemic Agents / HMG-CoA Reductase Inhibitors (i.e. Statins) Cardiovascular Drugs, a-Adrenergic ... Cardiovascular Drugs, Vasodilating Agents Cardiovascular Drugs/Calcium-Channel Blocking Agents Central Nervous System Agents - ... Respiratory Tract Agents, Vasodilating Agents Respiratory Tract Agents: Antifibrotic Agents Respiratory Tract Agents: ... Cardiovascular Drugs, Calcium-Channel Blocking Agents Cardiovascular Drugs, Central a-Agonists Cardiovascular Drugs, Direct ...
ATC - C01CA17 - Midodrine - Drugs-about.com
White Tea | Save up to 40% Off - Shop Now!
These agents promote anti-inflammatory effects and cause to reduce bad cholesterol in your system, which leads to the risks of ... Lower chances of heart diseases and improved cardiovascular conditions. Polyphenols in white tea enable ones blood vessels to ... White teas health agents prevent and alleviate chronic health conditions, making life better lived and enjoyed with a cup of ... This teas composition provides agents to prevent sicknesses and treat existing health conditions. Get to know more about what ...
Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders | Heart
Currently, there is no evidence for a preferred antihypertensive agent in IJD disregarding an older report that ACE inhibitors ... Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis. Joint Bone Spine 2011;78:179-83. doi:10.1016/ ... Rheumatoid cachexia and cardiovascular disease. Nat Rev Rheumatol 2010;6:445-51. doi:10.1038/nrrheum.2010.105. ... Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann ...
Side Effects of Aldomet (methyldopa): Interactions & Warnings
Cardiovascular: Aggravation of angina pectoris, congestive heart failure, prolonged carotid sinus hypersensitivity, orthostatic ... However, significant adverse effects due to Aldomet (methyldopa) have been infrequent and this agent usually is well tolerated. ... Take this quiz and test your IQ of high blood pressure (hypertension), the cardiovascular disease that causes most strokes and ...
2 Evaluating Exposure to Secondhand Smoke | Secondhand Smoke Exposure and Cardiovascular Effects: Making Sense of the Evidence ...
Of intrinsic health interest (known cardiovascular agent). Present at high levels in secondhand smoke facilitating easy ... Secondhand Smoke Exposure and Cardiovascular Effects: Making Sense of the Evidence (2010) Chapter: 2 Evaluating Exposure to ... The effect of legislation to ban smoking and its effects on the cardiovascular health of nonsmoking adults, however, remains a ... 4 Epidemiologic Studies of Secondhand-Smoke Exposure and Cardiovascular Disease 95-108 ...
Cardiovascular disease - Wikipedia
The use of vasoactive agents for people with pulmonary hypertension with left heart disease or hypoxemic lung diseases may ... Cardiovascular risk assessment. Existing cardiovascular disease or a previous cardiovascular event, such as a heart attack or ... Klatsky AL (May 2009). "Alcohol and cardiovascular diseases". Expert Review of Cardiovascular Therapy. 7 (5): 499-506. doi: ... Statins are effective in preventing further cardiovascular disease in people with a history of cardiovascular disease.[159] As ...
海洋天然物11-epi-sinulariolideacetate對於佐劑誘發類風濕性
Cardiovascular and hematological agents. 2:13-9.. Mayer A.M., and Hamann M.T., (2002) Marine pharmacology in 1999: compounds ... a novel class of anti-inflammatory agents. Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents. 3:271-301. ... Klein L.E., Freeze B.S., Smith A.B. 3rd, and Horwitz S.B., (2005) The microtubule stablizing agent discodermolide is a potent ... Weinheimer A.J., Matson J.A., Hossain, M.B., and Vander H.D., (1977) Marine anticancer agents: Sinularin and dihydrosinularin, ...
The Framingham Risk Score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease | Annals...
Cardiovascular risk factors assessment. Information about smoking status and the use of lipid-lowering agents and ... Assessment of cardiovascular risk in rheumatoid arthritis: impact of the new EULAR recommendations on the score cardiovascular ... Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 2004;19:225-30. ... Cardiovascular risk in rheumatoid arthritis: pathogenesis, diagnosis, and management. J Clin Rheumatol 2012;18:422-30. ...
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
Alternatively, some cardiovascular events may have been a consequence of HIV infection, of antiretroviral therapy, or of a ... 3.7% used lipid lowering agents. Body Mass Index: 4.8% had BMI >30; median BMI was 23.0. 11% had family history of ... However, many of the subjects had cardiovascular risk factors: 56.2 percent were current or previous smokers and 2.8 percent ... Thus, some degree of the cardiovascular risk discussed above may have been the result of predisposing factors, independently of ...
Research lines - Lipids & Liver Research Group - UPV/EHU
Obesity, metabolic hepatic steatosis (MAFLD) and cardiovascular disease: new metabolic agents and treatment targets.. The ... Obesity, metabolic hepatic steatosis (MAFLD) and cardiovascular disease: new metabolic agents and treatment targets. ... Mortality in NASH is frequently associated with cardiovascular disease and an increased risk of cancer. Therefore, it seems ...
DOTmed News Search: Lynn%252520Shapiro
Medicare & Your Heart: Cardiovascular Screenings & Treatments
Medicare is likely to cover cardiovascular screenings and procedures if youve experienced certain conditions. Learn more about ... This is a solicitation of insurance, and your response may generate communication from a licensed producer/agent.. We/Our ... Part B covers cardiovascular screening blood tests every five years. Other preventive measures include cardiovascular disease ... Cardiovascular Procedures Covered Under Medicare. Cardiovascular procedures, such as open heart surgery and heart transplants, ...
Supplies - 640011-2021 - TED Tenders Electronic Daily
33622600 - Beta-blocking agents. 33670000 - Medicinal products for the respiratory system. 33651520 - Immunoglobulins. 33661200 ... 33622000 - Medicinal products for the cardiovascular system. 33731110 - Intraocular lenses. 33610000 - Medicinal products for ... 33621100 - Antithrombotic agents. 33674000 - Cough and cold preparations. 33642100 - Pituitary, hypothalamic hormones and ... 33694000 - Diagnostic agents. 33661000 - Medicinal products for the nervous system. 33662100 - Ophthalmologicals. 33651100 - ...
Thieme E-Journals - Endoscopy / Abstract
Protecting Cardiovascular Health - page 1 - Life Extension
As cardiovascular disease claims more lives than any other disease in America today, grape seed extract may offer much-needed ... Protecting Cardiovascular Health with Whole Grape Extract. Recent studies point to the broad spectrum benefits of whole grape ... Cardiovascular disease involves a cascade of aberrant biological processes, but one area of interest even amongst the medical ... Nowhere are the "blessings of the grape" so evident as in prevention of cardiovascular disease.3 While many factors-ranging ...